Position in NBIX
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$1,759,389
+$753,028 QoQ
Shares Held
10,439
+36.7% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#328
of 768 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Vestcor Inc holds $18,826,284 across 17 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (9.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
13,447 | $7,285,988 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
This page
|
10,439 | $1,759,389 | |
| 3 | ALKS |
Alkermes plc.
|
30,230 | $1,584,052 | |
| 4 | INDV |
Indivior Pharmaceuticals, Inc.
|
34,263 | $1,405,810 | |
| 5 | VTRS |
Viatris Inc
|
87,478 | $1,389,150 | |
| 6 | AMRX |
Amneal Pharmaceuticals, Inc.
|
71,721 | $1,241,490 | |
| 7 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
13,123 | $839,215 | |
| 8 | ZTS |
Zoetis Inc.
|
11,578 | $831,995 |
All Filings in NBIX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,759,389 | 10,439 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $1,006,361 | 7,639 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $3,464,055 | 24,424 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $3,192,802 | 22,744 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $2,704,094 | 21,514 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $2,370,268 | 21,431 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $2,711,709 | 19,866 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $2,328,365 | 20,208 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $3,454,415 | 25,092 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $3,460,688 | 25,092 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $3,340,116 | 25,350 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,741,512 | 24,369 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,625,826 | 17,241 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $1,360,599 | 13,442 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,605,512 | 13,442 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $745,169 | 7,016 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $216,015 | 2,216 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $140,625 | 1,500 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $289,237 | 3,396 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $371,938 | 3,878 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $394,729 | 4,056 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $241,082 | 2,479 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $237,612 | 2,479 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $238,380 | 2,479 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $302,438 | 2,479 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||